CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY (Tables)

12 Months Ended

Dec. 31, 2025

Condensed Financial Information Disclosure [Abstract]

Schedule of Condensed Balance Sheets

The following presents condensed financial statements pertaining only to FWFI (dollars in thousands). Investments in subsidiaries are stated using the equity method of accounting.

	December 31,
Condensed Balance Sheets	2025		2024
Assets
Cash and cash equivalents	$	7,803	$	17,178
Investment in subsidiaries	299,668		282,491
Other assets	3,148		5,474
Total assets	$	310,619	$	305,143
Liabilities
Subordinated notes	$	44,772	$	52,565
Other liabilities	287		256
Total liabilities	45,059		52,821
Shareholders' Equity
Total shareholders’ equity	265,560		252,322
Total liabilities and shareholders’ equity	$	310,619	$	305,143

Schedule of Condensed Statements of Income

	Year Ended December 31,
Condensed Statements of Income	2025		2024
Income
Non-interest loss	(11)		(338)
Total loss	(11)		(338)
Expense
Interest expense	2,656		2,951
Non-interest expense	366		309
Total expense	3,022		3,260
Loss before income tax and equity in undistributed income of subsidiaries	(3,033)		(3,598)
Income tax benefit	687		454
Loss before equity in undistributed income of subsidiaries	(2,346)		(3,144)
Equity in undistributed income to subsidiaries	15,534		11,617
Net income	$	13,188	$	8,473

Schedule of Condensed Statements of Cash Flows

	Year Ended December 31,
Condensed Statements of Cash Flows	2025		2024
Cash flows from operating activities
Net income	$	13,188	$	8,473
Adjustments:
Amortization	207		225
Undistributed equity in subsidiaries	(15,534)		(11,617)
Change in other assets	2,326		56
Change in other liabilities	30		(147)
Net cash provided by (used in) operating activities	217		(3,010)
Cash flows from financing activities
Payments to subordinated note holders	(8,000)		—
Repurchase of common stock	(784)		(89)
Net settlement of restricted stock	(802)		(706)
Net settlement of exercised stock options	(6)		—
Net cash used in financing activities	(9,592)		(795)
Net change in cash and cash equivalents	(9,375)		(3,805)
Cash and cash equivalents, beginning of year	17,178		20,983
Cash and cash equivalents, end of year	$	7,803	$	17,178
Supplemental cash flow information:
Interest paid on borrowed funds	$	2,625	$	2,950
Supplemental noncash disclosures:
Stock-based compensation	$	2,173	$	1,486